The Process of Structure-Based Drug Design

Roberts, 1990, Rational design of peptide-based HIV proteinase inhibitors, Science, 248, 358, 10.1126/science.2183354

Erickson, 1990, Design, activity and 2.8 Å crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease, Science, 249, 527, 10.1126/science.2200122

Dorsey, 1994, L-735,524, J. Med. Chem., 37, 3443, 10.1021/jm00047a001

Mountain, 2003, Astex, Structural Genomix, and Syrrx, Chem. Biol., 10, 95, 10.1016/S1074-5521(03)00030-9

Zheng, 2003, Automated protein fold determination using a minimal NMR constraint strategy, Protein Sci., 12, 1232, 10.1110/ps.0300203

Oezguen, 2002, Automated assignment and 3D structure calculations using combinations of 2D homonuclear and 3D heteronuclear NOESY spectra, J. Biomol. NMR, 22, 249, 10.1023/A:1014925824100

Bailey-Kellogg, 2000, The NOESY jigsaw, J. Comput. Biol., 7, 537, 10.1089/106652700750050934

Pervushin, 1997, Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anistropy indicates an avenue to NMR structures of very large biological macromolecules in solution, Proc. Natl. Acad. Sci. USA, 94, 12366, 10.1073/pnas.94.23.12366

Antel, 1999, Integration of combinatorial chemistry and structure-based drug design, Curr. Opin. Drug Discov. Dev., 2, 224

Verlinde, 1994, Structure-based drug design, Structure, 2, 577, 10.1016/S0969-2126(00)00060-5

Taylor, 2002, A review of protein-small molecule docking methods, J. Comput. Aided Mol. Des., 16, 151, 10.1023/A:1020155510718

Joseph-McCarthy, 1999, Computational approaches to structure-based ligand design, Pharmacol. Ther., 84, 179, 10.1016/S0163-7258(99)00031-5

Carlson, 1999, Method for including the dynamic fluctuations of a protein in computer-aided drug design, J. Phys. Chem. A, 103, 10213, 10.1021/jp991997z

Bohacek, 1997, Modern computational chemistry and drug discovery, Curr. Opin. Chem. Biol., 1, 157, 10.1016/S1367-5931(97)80004-X

Carlson, 2000, Accommodating protein flexibility in computational drug design, Mol. Pharmacol., 57, 213

Shoichet, 2002, Lead discovery using molecular docking, Curr. Opin. Chem. Biol., 6, 439, 10.1016/S1367-5931(02)00339-3

Klebe, 1997, Energetic and entropic factors determining binding affinity in protein-ligand complexes, J. Recept. Signal Transduct. Res., 17, 459, 10.3109/10799899709036621

Gallego, 2001, Targeting RNA with small-molecule drugs, Acc. Chem. Res., 34, 836, 10.1021/ar000118k

Afshar, 1999, Structure-based and combinatorial search for new RNA-binding drugs, Curr. Opin. Biotechnol., 10, 59, 10.1016/S0958-1669(99)80011-1

Hopkins, 2002, The druggable genome, Nat. Rev. Drug Discov., 1, 727, 10.1038/nrd892

Kaelin, 1999, Choosing anticancer drug targets in the postgenomic era, J. Clin. Invest., 104, 1503, 10.1172/JCI8888

Lukasik, 2002, Altered affinity of CBFb-SMMHC for Runx1 explains its role in leukemogenesis, Nat. Struct. Biol., 9, 674, 10.1038/nsb831

Nissen, 2000, The structural basis of ribosome activity in peptide bond synthesis, Science, 289, 920, 10.1126/science.289.5481.920

Luzzati, 1952, The statistical treatment of errors in crystal structures, Acta Crystallogr., 5, 802, 10.1107/S0365110X52002161

Stroud, 1995, Significance of structural changes in proteins, Protein Sci., 4, 2392, 10.1002/pro.5560041118

Carson, 1994, Comparison of homology model to the experimental structure of a novel serine protease, Acta Crystallogr. D Biol. Crystallogr., 50, 889, 10.1107/S0907444994004907

Laskowski, 1993, Procheck, J. Appl. Crystallogr., 26, 283, 10.1107/S0021889892009944

Pellecchia, 2002, NMR in drug discovery, Nat. Rev. Drug Discov., 1, 211, 10.1038/nrd748

Doreleijers, 1998, Quality assessment of NMR structures, J. Mol. Biol., 281, 149, 10.1006/jmbi.1998.1808

Laskowski, 1996, Aqua and procheck-nmr, J. Biomol. NMR, 8, 477, 10.1007/BF00228148

Vriend, 1990, What if, J. Mol. Graph., 8, 52, 10.1016/0263-7855(90)80070-V

Enyedy, 2001, Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase, J. Med. Chem., 44, 1349, 10.1021/jm000395x

Enyedy, 2001, Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening, J. Med. Chem., 44, 4313, 10.1021/jm010016f

Schapira, 2001, In silico discovery of novel retinoic acid receptor agonist structures, BMC Struct. Biol., 1, 1, 10.1186/1472-6807-1-1

Peitsch, 1997, Large-scale comparative protein modeling

Lind, 2002, Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA, Chem. Biol., 9, 185, 10.1016/S1074-5521(02)00106-0

Filikov, 2000, Identification of ligands for RNA targets via structure-based virtual screening, J. Comput. Aided Mol. Des., 14, 593, 10.1023/A:1008121029716

Gadek, 2003, Small molecule antagonists of proteins, Biochem. Pharmacol., 65, 1, 10.1016/S0006-2952(02)01479-X

Tilley, 1997, Identification of a small molecule inhibitor of the IL-2/IL-2R receptor interaction which binds IL-2, J. Am. Chem. Soc., 119, 7589, 10.1021/ja970702x

Wiesmann, 1998, Crystal structure of the complex between VEGF and a receptor-blocking peptide, Biochemistry, 37, 117765, 10.1021/bi9819327

Varney, 1992, Crystal structure-based drug design and synthesis of benz[cd]indole-containing inhibitors of thymidylate synthase, J. Med. Chem., 35, 663, 10.1021/jm00082a006

Chan, 2001, Structural studies on bioactive compounds. 34. Design, synthesis, and biological evaluation of triazenyl-substituted pyrimethamine inhibitors of Pneumocystis carinii dihydrofolate reductase, J. Med. Chem., 44, 2555, 10.1021/jm0108698

Carlson, 2002, Protein flexibility and drug design, Curr. Opin. Chem. Biol., 6, 447, 10.1016/S1367-5931(02)00341-1

Rutenber, 1996, Binding of the anticancer drug ZD1694 to E. coli thymidylate synthase, Structure, 4, 1317, 10.1016/S0969-2126(96)00139-6

Stout, 1996, The complex of the anti-cancer therapeutic, BW1843U89, with thymidylate synthase at 2.0 Å resolution, Structure, 4, 67, 10.1016/S0969-2126(96)00010-X

Kuntz, 1982, A geometric approach to macromolecular-ligand interactions, J. Mol. Biol., 161, 269, 10.1016/0022-2836(82)90153-X

Lorber, 1998, Flexible ligand docking using conformational ensembles, Protein Sci., 7, 938, 10.1002/pro.5560070411

Ewing, 2001, Dock 4.0, J. Comput. Aided Mol. Des., 15, 411, 10.1023/A:1011115820450

Shoichet, 1999, Ligand solvation in molecular docking, Proteins, 34, 4, 10.1002/(SICI)1097-0134(19990101)34:1<4::AID-PROT2>3.0.CO;2-6

Schnecke, 1998, Screening a peptidyl database for potential ligands to proteins with side-chain flexibility, Proteins, 33, 74, 10.1002/(SICI)1097-0134(19981001)33:1<74::AID-PROT7>3.0.CO;2-L

Kramer, 1999, Ligand docking and screening with FlexX, Med. Chem. Res., 9, 463

Claussen, 2001, FlexE. Efficient molecular docking considering protein structure variations, J. Mol. Biol., 308, 377, 10.1006/jmbi.2001.4551

Boehm, 1996, Towards the automatic design of synthetically accessible protein ligands, J. Comput. Aided Mol. Des., 10, 265, 10.1007/BF00124496

Boehm, 1992, The computer program, LUDI, J. Comput. Aided Mol. Des., 6, 61, 10.1007/BF00124387

Goodford, 1985, A computational procedure for determining energetically favorable binding sites on biologically important macromolecules, J. Med. Chem., 28, 849, 10.1021/jm00145a002

Caflisch, 1993, Multiple copy simultaneous search and construction of ligands in binding sites, J. Med. Chem., 36, 2142, 10.1021/jm00067a013

Pearlman, 1996, Concerts, J. Med. Chem., 39, 1651, 10.1021/jm950792l

DeWitte, 1996, Smog, J. Am. Chem. Soc., 118, 11733, 10.1021/ja960751u

Davis, 1999, Hydrogen bonding, hydrophobic interactions, and failure of the rigid receptor hypothesis, Angew. Chem. Int. Ed. Engl., 38, 736, 10.1002/(SICI)1521-3773(19990315)38:6<736::AID-ANIE736>3.0.CO;2-R

Anderson, 2001, Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking, Chem. Biol., 8, 445, 10.1016/S1074-5521(01)00023-0

Knegtel, 1997, Molecular docking to ensembles of protein structures, J. Mol. Biol., 266, 424, 10.1006/jmbi.1996.0776

Carlson, 2000, Developing a dynamic pharmacophore model for HIV-1 integrase, J. Med. Chem., 43, 2100, 10.1021/jm990322h

Lovell, 2000, The penultimate rotamer library, Proteins, 40, 389, 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2

Ota, 2001, Binding mode prediction for a flexible ligand in a flexible pocket using multi-conformation simulated annealing pseudo crystallographic refinement, J. Mol. Biol., 314, 607, 10.1006/jmbi.2001.5147

Lam, 1994, Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors, Science, 263, 380, 10.1126/science.8278812

Powers, 2002, Structure-based discovery of a novel, noncovalent inhibitor of AmpC beta-lactamase, Structure, 10, 1013, 10.1016/S0969-2126(02)00799-2

Majeux, 2001, Efficient electrostatic solvation model for protein-fragment docking, Proteins, 42, 256, 10.1002/1097-0134(20010201)42:2<256::AID-PROT130>3.0.CO;2-4

Bohm, 1998, Prediction of binding constants of protein ligands, J. Comput. Aided Mol. Des., 12, 309, 10.1023/A:1007999920146

Lipinski, 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev., 23, 3, 10.1016/S0169-409X(96)00423-1

Veber, 2002, Molecular properties that influence the oral bioavailability of drug candidates, J. Med. Chem., 45, 2615, 10.1021/jm020017n

Fritz, 2001, Predicting and harnessing protein flexibility in the design of species-specific inhibitors of thymidylate synthase, Chem. Biol., 8, 981, 10.1016/S1074-5521(01)00067-9

Kaldor, 1997, Viracept (Nelfinavir Mesylate AG1343), J. Med. Chem., 40, 3979, 10.1021/jm9704098

Varghese, 1999, Development of neuraminidase inhibitors as anti-influenza virus drugs, Drug Dev. Res., 46, 176, 10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6

Schindler, 2000, Structural mechanism for STI-571 inhibition of abelson tyrosine kinase, Science, 289, 1938, 10.1126/science.289.5486.1938

Powers, 2002, Structure-based approach for binding site identification on AmpC β-lactamase, J. Med. Chem., 45, 3222, 10.1021/jm020002p

McMartin, 1997, Qxp, J. Comput. Aided Mol. Des., 11, 333, 10.1023/A:1007907728892

Mitzutani, 1994, Rational automatic search method for stable docking models of protein and ligand, J. Mol. Biol., 243, 310, 10.1006/jmbi.1994.1656

Welch, 1996, Hammerhead, Chem. Biol., 3, 449, 10.1016/S1074-5521(96)90093-9

Goodsell, 1996, Automated docking of flexible ligands, J. Mol. Recognit., 9, 1, 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6

Liu, 1999, Mcdock, J. Comput. Aided Mol. Des., 13, 435, 10.1023/A:1008005918983

Trosset, 1999, Prodock, J. Comput. Chem., 20, 412, 10.1002/(SICI)1096-987X(199903)20:4<412::AID-JCC3>3.0.CO;2-N

Abagyan, 1994, ICM—a new method for protein modeling and design—applications to docking and structure prediction from the distorted native conformation, J. Comput. Chem., 15, 488, 10.1002/jcc.540150503

Hart, 1992, Proteins, 13, 206, 10.1002/prot.340130304

Nishibata, 1993, Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation, J. Med. Chem., 36, 2921, 10.1021/jm00072a011

Miranker, 1995, An automated method for dynamic ligand design, Proteins, 23, 472, 10.1002/prot.340230403

Bohacek, 1994, Multiple highly diverse structues complementary to enzyme binding sites, J. Am. Chem. Soc., 116, 5560, 10.1021/ja00092a006

Rotstein, 1993, GenStar, J. Comput. Aided Mol. Des., 7, 23, 10.1007/BF00141573

Moon, 1991, Computer design of bioactive molecules, Proteins, 11, 29, 10.1002/prot.340110409

Rotstein, 1993, GroupBuild, J. Med. Chem., 36, 1700, 10.1021/jm00064a003

Eisen, 1994, Hook, Proteins, 19, 199, 10.1002/prot.340190305

Gillet, 1993, Sprout, J. Comput. Aided Mol. Des., 7, 127, 10.1007/BF00126441

Bartlett, 1989, Caveat

Polshakov, 2001, NMR-based solution structure of the complex of Lactobacillus casei dihydrofolate reductase with trimethoprim and NADPH, J. Biomol. NMR, 24, 67, 10.1023/A:1020659713373